We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-2.46%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$392B
AUM Growth
-$22.8B
Cap. Flow
-$849M
Cap. Flow %
-0.22%
Top 10 Hldgs %
11.81%
Holding
4,189
New
137
Increased
2,071
Reduced
1,612
Closed
191

Top Buys

Rank Stock Value
1
HEI.A icon
HEICO Corp Class A
HEI.A
+$873M
2
FERG icon
Ferguson
FERG
+$750M
3
UNH icon
UnitedHealth
UNH
+$641M
4
AAPL icon
Apple
AAPL
+$619M
5
V icon
Visa
V
+$612M

Sector Composition

Rank Sector Weight
1 Technology 19.91%
2 Financials 13.06%
3 Healthcare 12.67%
4 Consumer Discretionary 10.55%
5 Industrials 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COGT icon
3751
Cogent Biosciences
COGT
$6.76B
$92K ﹤0.01%
12,258
+459
+4% +$3.2K
RKLB icon
3752
Rocket Lab Corp
RKLB
$36.6B
$92K ﹤0.01%
11,527
-2,008
-15% -$18.7K
SOS
3753
SOS Limited
SOS
$17.2M
$92K ﹤0.01%
228
+50
+28% +$27.3K
VSTM icon
3754
Verastem
VSTM
$528M
$91K ﹤0.01%
5,399
+188
+4% +$3.24K
HBIO icon
3755
Harvard Bioscience
HBIO
$27.6M
$89K ﹤0.01%
1,441
-3,919
-73% -$232K
SLGL icon
3756
Sol-Gel Technologies
SLGL
$270M
$89K ﹤0.01%
1,203
-322
-21% -$23.9K
CRIS icon
3757
Curis
CRIS
$9.71M
$88K ﹤0.01%
93
+1
+1% +$1.28K
VLDR
3758
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$86K ﹤0.01%
33,555
-1,039
-3% -$3.55K
NEUE
3759
DELISTED
NeueHealth
NEUE
$83K ﹤0.01%
538
+321
+148% +$71.3K
LUNA
3760
DELISTED
Luna Innovations Incorporated
LUNA
$83K ﹤0.01%
10,786
+137
+1% +$985
TOON icon
3761
Kartoon Studios
TOON
$34M
$82K ﹤0.01%
8,082
+131
+2% +$1.23K
VTGN icon
3762
VistaGen Therapeutics
VTGN
$9.98M
$81K ﹤0.01%
2,189
+24
+1% +$1.05K
CANO
3763
DELISTED
Cano Health, Inc.
CANO
$81K ﹤0.01%
128
-22
-15% -$13.9K
ABUS icon
3764
Arbutus Biopharma
ABUS
$847M
$80K ﹤0.01%
26,898
+1,513
+6% +$4.63K
AAIC
3765
DELISTED
Arlington Asset Investment Corp.
AAIC
$80K ﹤0.01%
22,930
-44,507
-66% -$154K
AMTI
3766
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$78K ﹤0.01%
10,347
+117
+1% +$969
SPPI
3767
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$76K ﹤0.01%
58,745
-852,164
-94% -$785K
ALT icon
3768
Altimmune
ALT
$568M
$75K ﹤0.01%
12,318
+487
+4% +$3.59K
VKTX icon
3769
Viking Therapeutics
VKTX
$3.88B
$75K ﹤0.01%
24,713
-34,635
-58% -$124K
SDIG
3770
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$75K ﹤0.01%
1,285
-190
-13% -$19.9K
RAAS
3771
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$75K ﹤0.01%
14,541
-378
-3% -$2.41K
ALDX icon
3772
Aldeyra Therapeutics
ALDX
$97.1M
$73K ﹤0.01%
16,375
-378
-2% -$1.51K
JNCE
3773
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$73K ﹤0.01%
10,767
+579
+6% +$4.13K
PLRX icon
3774
Pliant Therapeutics
PLRX
$65M
$72K ﹤0.01%
10,200
+189
+2% +$1.93K
APYX icon
3775
Apyx Medical
APYX
$162M
$71K ﹤0.01%
10,861
+93
+0.9% +$916

Similar funds

Invesco's Q1 2022 Portfolio in Review

As of Q1 2022, Invesco held 4,189 positions worth $392B, down 5.5% from $415B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Invesco's Q1 2022 filing shows 137 new, 2,071 increased, 1,612 reduced and 191 closed positions. Its largest new stake was Ferguson: 4,859,882 shares worth $652M. The largest sale was Vale, an estimated $814M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Invesco's largest Q1 2022 buy was Ferguson: 4,859,882 shares worth $652M.
  • Invesco added most to HEICO Corp Class A in Q1 2022, an estimated $873M increase.
  • Invesco's biggest Q1 2022 reduction was Vale, cutting an estimated $814M.
  • Invesco fully exited Xilinx Inc in Q1 2022, selling an estimated $200M.
  • Invesco's ten largest holdings make up 12% of its $392B portfolio in Q1 2022.
  • Invesco opened 137 new positions and closed 191 in Q1 2022.
  • Invesco's portfolio value fell 5.5% quarter-over-quarter to $392B.

Based on Invesco's 13F filing for Q1 2022, filed 16 May 2022.